FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

Anglo American PLC De Beers rough diamond sales 7th cycle of 2019

Anglo American plc (LON:AAL) today announced the value of rough diamond sales (Global Sightholder Sales and Auction Sales) for De Beers’ seventh sales cycle of 2019, amounting to $280 million...

AstraZeneca PLC Fasenra granted US Orphan Drug Designation

AstraZeneca plc (LON:AZN) today announced that the US Food and Drug Administration has granted Orphan Drug Designation to Fasenra (benralizumab) for the treatment of eosinophilic oesophagitis (EoE). EoE is a..

Bunzl plc Resilient operating performance

Bunzl plc (LON:BNZL), the specialist international distribution and services Group, today publishes its half yearly financial report for the six months ended 30 June 2019. Financial results As reported under..

GSK announces positive headline results from the pivotal DREAMM-2 study

GlaxoSmithKline plc (LON/NYSE: GSK) today announced positive headline results from the pivotal DREAMM-2 open-label, randomised study of two doses of belantamab mafodotin (GSK2857916). The 196 patients in the trial had..

CRH PLC Continues Share Buyback Programme

As part of its 2019 Interim Results on 22 August 2019, CRH PLC (LON:CRH) announced its intention to continue its share buyback programme with a further tranche of up to..

AstraZeneca plc agrees to buy US FDA Priority Review Voucher from Sobi

AstraZeneca plc (LON:AZN) today announced that it has agreed to buy a US Food and Drug Administration Priority Review Voucher for a total cash consideration of $95m from a subsidiary..

NMC Health PLC Strong performance for H1 2019 in core markets of UAE

NMC Health PLC (LON:NMC), the leading Gulf Cooperation Council and international private healthcare operator, has today announced its results for the six months ended 30 June 2019. Key Highlights ·      Strong..

GlaxoSmithKline PLC ViiV results positive for every 2 month injection

GlaxoSmithKline PLC (LON: GSK) ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced positive headline results from its..

NMC Health Plc Share buyback programme

NMC Health PLC (LON:NMC) today announced that it intends to immediately initiate the process to seek shareholder approval for a share buyback programme. The buyback authority will require formal approval..

Antofagasta PLC Deliver robust financial results for H1

Antofagasta PLC (LON: ANTO) have today announced its half year report for the six months ended 30th June 2019. Antofagasta plc CEO Iván Arriagada said: “We have delivered robust financial..

AstraZeneca PLC Roxadustat approved in China for the treatment of anaemia

AstraZeneca (LON: AZN) today announced that its partner FibroGen (China) Medical Technology Development Co., Ltd. (FibroGen China) has received marketing authorisation for roxadustat in China for the treatment of anaemia..

AstraZeneca PLC Update on the Phase III NEPTUNE trial

AstraZeneca plc (LON: AZN) today announced final overall survival results from the Phase III NEPTUNE trial, a randomised, open-label, multi-centre, global trial of Imfinzi (durvalumab) in combination with tremelimumab, an..

BHP Group Results Presentation Year Ended 30 June 2019

BHP Group (LON: BHP) have today announced that its ‘Results Presentation Year Ended 30 June 2019’ has today been submitted to the National Storage Mechanism and will shortly be available..

Persimmon Plc in a strong position for the second half

Persimmon Plc (LON:PSN) today announced its half year results for the six months ended 30 June 2019. Highlights “Improving the quality and service delivered to our customers remains our top..

AstraZeneca PLC Farxiga met primary endpoint in landmark Phase III

Farxiga met primary endpoint in landmark Phase III DAPA-HF trial for the treatment of patients with heart failure DAPA-HF is the first heart failure outcomes trial with an SGLT2 inhibitor..

AstraZeneca plc appoints Michel Demaré to its Board of Directors

AstraZeneca plc (LON:AZN) today announced that, with effect from 1 September 2019, Michel Demaré is appointed as a Non-Executive Director and a member of the Audit Committee. Leif Johansson, Chairman..

United Utilities Group PLC Dr John McAdam moves to ConvaTec Group Plc

United Utilities Group PLC (LON: UU.) announced today that in accordance with Listing Rule 9.6.14(2) Dr John McAdam, chairman, has been appointed as chairman of ConvaTec Group Plc with effect..

Standard Life Aberdeen plc Share Repurchase Programme

On 15 August 2019, Standard Life Aberdeen plc (LON:SLA) entered into a non-discretionary instruction with Citigroup Global Markets Limited in relation to the purchase by Citi, acting as principal, of..

Anglo American plc Share Buyback

Anglo American plc (LON: AAL) announced today that it has purchased the following number of its ordinary shares of US$0.54945 each on Exchange (as defined in the Rules of the..

The Berkeley Group Holdings plc Dividend Update

Berkeley Group Holdings (LON: BKG) have today announced that an interim dividend of 20.08 pence per share will be paid on 13 September 2019 to shareholders on the Company’s register..

Search

Funds

FTSE 100

Search

Funds

FTSE 100

FTSE 100

Funds